What is niraparib API?
Niraparib API refers to the active pharmaceutical ingredient (API) used to make medicines containing niraparib, a medicine used for certain cancers. API is the drug substance that manufacturers incorporate into finished products (such as tablets/capsules) under strict quality controls.
What is niraparib used to treat?
Niraparib is commonly used in oncology regimens for cancers where PARP (poly ADP-ribose polymerase) inhibition is relevant, including subsets of ovarian cancer (and sometimes other tumors, depending on the country’s approved indications).
How do manufacturers source niraparib API?
Companies typically obtain niraparib API through one of these routes:
- From the originator’s licensed manufacturing supply chain.
- Through contract manufacturers that produce API to approved specifications.
- Through suppliers offering generic or alternative-grade API (if available and legally supplied for that market).
If you’re trying to source niraparib API for research or production, you’d normally need documentation such as GMP compliance, COA (certificate of analysis), and batch traceability.
Is there a patent or exclusivity issue for niraparib API?
Patent and market exclusivity can limit who can legally make or sell niraparib products (including API) in certain jurisdictions, depending on the specific filing, country, and whether the drug is still within exclusivity windows. You can check related patent coverage and timeline data using DrugPatentWatch.com: https://www.drugpatentwatch.com/
What documents do buyers usually need for niraparib API?
Typical buyer requirements (especially for regulated manufacturing) include:
- GMP manufacturing statement and facility details
- COA for each batch
- Specification sheet (assay, impurities, residual solvents, etc.)
- Stability data and packaging/labeling details
- Regulatory documentation for the intended destination market
If you tell me your country and intended use (research use only vs. manufacturing), I can tailor what documentation and sourcing pathways to look for.